How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Close this folder8 EVALUATION
View the documentEvaluation of the NF within the framework of existing monitoring and evaluation activities
View the documentHow to design the evaluation
Close this folderWhat to evaluate
View the documentPolicy, legal framework and management support
View the documentSelection
View the documentProcurement
View the documentDistribution of formulary
View the documentRational use
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Selection

Indicators

1. Percentage of essential medicines by active ingredient from the national EML included in the NF list

Calculate:

Number of unique essential medicinal products on the national EML x 100

Number of unique medicinal products in the NF

Unique: Products with the same active ingredient, dosage form, to be administered by the same route listed both in EML and NF. If there are several strengths of the same product available they will be counted as one product (not unique).

2. Percentage of essential medicines from the WMF adopted in the NF

Calculate:

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014